Tvardi Therapeutics TVRD
NASDAQ TVRD
$1.41 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Tvardi Therapeutics (TVRD) EV to FCF (2014 - 2025)

Updated

Tvardi Therapeutics' EV to FCF was -2.60 in Q1 2025.

Analysis

Tvardi Therapeutics (TVRD) EV to FCF (2014 - 2025) Analysis & Trends

On a trailing twelve-month basis, Tvardi Therapeutics' EV to FCF was -33.26 through Mar 31, 2025.

  • The Q1 2025 figure marks the highest quarterly EV to FCF since Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Tvardi Therapeutics 13.23 Mn -94.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -2.60
Sep 30, 2021 27.34
Jun 30, 2021 35.93
Mar 31, 2021 102.42
Jun 30, 2018 419.89
Mar 31, 2014 144.13
API Access

Tvardi Therapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=TVRD&period=max&api_key=YOUR_API_KEY